Approval · Notice of Compliance 1057 · 2000
OMNICEF CAPSULES: Notice of Compliance 1057
Issued April 11, 2000
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1057
- Date
- April 11, 2000
- Company
- Abbott Laboratories Co.Saint-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Antibiotic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| OMNICEF CAPSULES | 02239563 | — |
Medicinal ingredients
- CEFDINIR 300 MG per CAP